Bibliotecas PUC-SP - Busca Integrada

Caplacizumab in adult patients with acquired thrombotic thrombocytopenic purpura

Por Ashley Hanlon, Ara Metjian
Publicado no Therapeutic Advances in Hematology (2020-02-01)

New advances in the treatment of adult chronic immune thrombocytopenic purpura: role of thrombopoietin receptor-stimulating agents

Por Ara Metjian, Charles S Abrams
Publicado no Biologics: Targets & Therapy (2009-12-01)

Waldenström Macroglobulinemia in Hepatitis C: Case Report and Review of the Current Literature

Por Ryan Nipp, Aaron Mitchell, Allyson Pishko, Ara Metjian
Publicado no Case Reports in Oncological Medicine (2014-01-01)

THE ROLE OF ADAMTS13 ACTIVITY LEVELS ON DISEASE EXACERBATION OR RELAPSE IN PATIENTS WITH IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA: POST HOC ANALYSIS OF THE PHASE 3 HERCU...

Por Johanna KREMER HOVINGA, Javier DE LA RUBIA, Katerina PAVENSKI, Ara METJIAN, Paul KNÖBL, Flora PEYVANDI, Spero CATALAND, Paul COPPO, Umer KHAN, Laurel A. MENAPACE, Ana PAULA MARQUES, Sriya GUNAWARDENA, Marie SCULLY
Publicado no Hematology, Transfusion and Cell Therapy (2023-10-01)

INTEGRATED EFFICACY RESULTS FROM THE PHASE 2 AND PHASE 3 STUDIES WITH CAPLACIZUMAB IN PATIENTS WITH ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA

Por Flora Peyvandi, Spero Cataland, Marie Scully, Paul Coppo, Paul Knoebl, Johanna A. Kremer Hovinga, Ara Metjian, Javier de la Rubia, Katerina Pavenski, Jessica Minkue Mi Edou, Filip Callewaert, Hilde De Winter
Publicado no Hematology, Transfusion and Cell Therapy (2021-11-01)

LONG-TERM OUTCOMES OF PATIENTS TREATED WITH CAPLACIZUMAB FOR IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA (ITTP): THE POST-HERCULES STUDY

Por Özgür Pektaş, Marie Scully, Javier de la Rubia, Katerina Pavenski, Ara Metjian, Paul Knöbl, Flora Peyvandi, Spero Cataland, Paul Coppo, Johanna A. Kremer Hovinga, Jessica Minkue Mi Edou, Rui de Passos Sousa, Sriya Gunawardena, Julie Lin
Publicado no Hematology, Transfusion and Cell Therapy (2022-10-01)

Relapse-free survival is progressively shortened in a subset of Black patients with immune-mediated TTP treated in the rituximab era

Por Ayotola Fatola, Michael D. Evans, Jenna Brown, Elizabeth Davis, Andrew Johnson, Ana G. Antun, Andrew M. Farland, Ryan Woods, Ara Metjian, Yara A. Park, Gustaaf de Ridder, Briana Gibson, Raj S. Kasthuri, Darla K. Liles, Susan Eubanks, Frank Akwaa, Todd Clover, Lisa Baumann Kreuziger, J. Evan Sadler, Meera Sridharan, Ronald S. Go, Keith R. McCrae, Harsh Vardhan Upreti, Ming Y. Lim, Nicole K. Kocher, Radhika Gangaraju, X. Long Zheng, Jay S. Raval, Camila Masias, Spero R. Cataland, Marshall Mazepa, Shruti Chaturvedi
Publicado no Blood Advances (2025-01-01)